Milne Jill C. has filed 9 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 528 shares of BIOCRYST PHARMACEUTICALS INC ($BCRX) on February 27, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Milne Jill C. | Director | A | Common Stock | 528 | $8.75 | 15,382.0000 | 219,885,000 | 3.55% | 0.00% |
| Jan. 23, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Milne Jill C. | Director | A | Automatic Stock Option Grant | 26684 | $0.00 | 26,684.0000 | 219,885,000 | 9999.99% | 0.01% |
| Jan. 23, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Milne Jill C. | Director | A | Common Stock | 2582 | $0.00 | 2,582.0000 | 219,885,000 | 9999.99% | 0.00% |
| Jan. 23, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Milne Jill C. | Director | A | Common Stock | 12272 | $0.00 | 14,854.0000 | 219,885,000 | 475.29% | 0.01% |
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | Milne Jill C. | CEO and President | D | Stock Option (Right to Buy) | 761000 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 1.31% |
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | Milne Jill C. | CEO and President | D | Common Stock | 4377 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.01% |
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | Milne Jill C. | CEO and President | D | Stock Option (Right to Buy) | 195000 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.34% |
| March 21, 2025 | Astria Therapeutics, Inc. | $ATXS | Milne Jill C. | CEO and President | A | Stock Option (Right to Buy) | 761000 | $0.00 | 761,000.0000 | 56,161,249 | 9999.99% | 1.36% |
| Feb. 8, 2024 | Astria Therapeutics, Inc. | $ATXS | Milne Jill C. | CEO and President | A | Stock Option (Right to Buy) | 534600 | $0.00 | 534,600.0000 | 30,123,316 | 9999.99% | 1.77% |